JPWO2022059763A1 - - Google Patents
Info
- Publication number
- JPWO2022059763A1 JPWO2022059763A1 JP2022550623A JP2022550623A JPWO2022059763A1 JP WO2022059763 A1 JPWO2022059763 A1 JP WO2022059763A1 JP 2022550623 A JP2022550623 A JP 2022550623A JP 2022550623 A JP2022550623 A JP 2022550623A JP WO2022059763 A1 JPWO2022059763 A1 JP WO2022059763A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020156457 | 2020-09-17 | ||
| PCT/JP2021/034211 WO2022059763A1 (ja) | 2020-09-17 | 2021-09-17 | オートファジー活性化剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022059763A1 true JPWO2022059763A1 (es) | 2022-03-24 |
Family
ID=80776039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550623A Pending JPWO2022059763A1 (es) | 2020-09-17 | 2021-09-17 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPWO2022059763A1 (es) |
| KR (1) | KR20230051238A (es) |
| CN (1) | CN116437912A (es) |
| TW (1) | TW202228676A (es) |
| WO (1) | WO2022059763A1 (es) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06271466A (ja) * | 1993-03-23 | 1994-09-27 | Asahi Chem Ind Co Ltd | 神経成長因子活性増強剤 |
| JP4111856B2 (ja) * | 2002-04-12 | 2008-07-02 | 昭和電工株式会社 | 安定化されたアスコルビン酸誘導体 |
| WO2013018779A1 (ja) | 2011-08-01 | 2013-02-07 | 株式会社林原 | α－グルコシルヘスペリジンの結晶とその用途 |
| JP6018800B2 (ja) * | 2012-05-25 | 2016-11-02 | ライオン株式会社 | 経口投与組成物 |
| CA2982161C (en) | 2015-04-08 | 2023-07-18 | BioMendics, LLC | Formulation and process for modulating wound healing |
| KR20170025604A (ko) * | 2015-08-31 | 2017-03-08 | 연세대학교 원주산학협력단 | 아스코르브산 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 퇴행성 신경질환 치료용 약학적 조성물 |
| EP3359526A4 (en) | 2015-10-05 | 2019-04-03 | The Trustees of Columbia University in the City of New York | ACTIVATORS OF AUTOPHAGIC FLOW AND PHOSPHOLIPASE D AND CLAIRANCE OF PROTEIN AGGREGATES COMPRISING TAU AND TREATMENT OF PROTEINEOPATHIES |
| JP7136765B2 (ja) | 2017-03-24 | 2022-09-13 | 株式会社林原 | オートファジー誘導剤とその用途 |
| JP2019011254A (ja) * | 2017-06-29 | 2019-01-24 | ちふれホールディングス株式会社 | 表皮肥厚抑制剤 |
| JP2019081718A (ja) * | 2017-10-30 | 2019-05-30 | 日光ケミカルズ株式会社 | ヒアルロン酸合成酵素発現促進剤 |
-
2021
- 2021-09-17 JP JP2022550623A patent/JPWO2022059763A1/ja active Pending
- 2021-09-17 TW TW110134831A patent/TW202228676A/zh unknown
- 2021-09-17 CN CN202180075902.XA patent/CN116437912A/zh active Pending
- 2021-09-17 KR KR1020237008543A patent/KR20230051238A/ko unknown
- 2021-09-17 WO PCT/JP2021/034211 patent/WO2022059763A1/ja active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022059763A1 (ja) | 2022-03-24 |
| TW202228676A (zh) | 2022-08-01 |
| KR20230051238A (ko) | 2023-04-17 |
| CN116437912A (zh) | 2023-07-14 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240802 |